Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood
- PMID: 9845492
- DOI: 10.1016/s0002-9343(97)00056-9
Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood
Abstract
Exposure to human immunodeficiency virus (HIV) does not necessarily induce infection or seroconversion defined by standard criteria based on enzyme-linked immunosorbent assay (ELISA), Western Blot, or polymerase chain reaction (PCR) techniques, but it can induce HIV-specific cell-mediated immune responses. Healthcare workers (HCWs) occupationally exposed to HIV represent a unique population with low-level exposure to HIV for whom time and type of exposure are specifically recorded. Although the frequency of seroconversion in HCWs occupationally exposed to HIV contaminated body fluids is relatively low, a higher proportion of HIV-exposed HCWs seem to exhibit in vitro cellular responses to HIV envelope peptides. Our findings indicate that parenteral exposure to HIV can induce cell-mediated immune responses in the absence of seroconversion. The significance of these responses is not known, but it is possible that the low incidence of HIV infection after exposure might be due, in part, to a protective cellular immune response to low HIV inocula.
Similar articles
-
HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood.JAMA. 1994 Jan 5;271(1):42-6. JAMA. 1994. PMID: 8258885
-
ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.J Clin Invest. 1995 Aug;96(2):867-76. doi: 10.1172/JCI118133. J Clin Invest. 1995. PMID: 7635981 Free PMC article.
-
Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus.Am J Med. 1997 May 19;102(5B):115-6. doi: 10.1016/s0002-9343(97)00076-4. Am J Med. 1997. PMID: 9845512 Review.
-
Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers.Infect Control Hosp Epidemiol. 1999 Jun;20(6):428-30. doi: 10.1086/501646. Infect Control Hosp Epidemiol. 1999. PMID: 10395147
-
Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure.Am J Med. 1997 May 19;102(5B):117-24; discussion 125-6. doi: 10.1016/s0002-9343(97)00077-6. Am J Med. 1997. PMID: 9845513 Review.
Cited by
-
Current perspectives in HIV post-exposure prophylaxis.HIV AIDS (Auckl). 2014 Oct 24;6:147-58. doi: 10.2147/HIV.S46585. eCollection 2014. HIV AIDS (Auckl). 2014. PMID: 25368534 Free PMC article. Review.
-
Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera.Virol J. 2005 Aug 17;2:65. doi: 10.1186/1743-422X-2-65. Virol J. 2005. PMID: 16107217 Free PMC article.
-
Awareness and low uptake of post exposure prophylaxis for HIV among clinical medical students in a high endemicity setting.BMC Public Health. 2015 Nov 6;15:1104. doi: 10.1186/s12889-015-2468-9. BMC Public Health. 2015. PMID: 26545721 Free PMC article.
-
Challenges in implementing the 2015 BASHH guidelines for the appropriate use of post-exposure prophylaxis for HIV following sexual exposure.F1000Res. 2016 Jun 9;5:1313. doi: 10.12688/f1000research.8952.1. eCollection 2016. F1000Res. 2016. PMID: 28649362 Free PMC article.
-
Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European setting.Eur J Epidemiol. 2004;19(6):577-84. doi: 10.1023/b:ejep.0000032349.57057.8a. Eur J Epidemiol. 2004. PMID: 15330131 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical